Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma
- PMID: 16997506
- DOI: 10.1016/j.ijrobp.2006.06.028
Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma
Abstract
Purpose: The aim of this study was to propose the clinical radiotherapy-related typing and to summarize proportional distribution of radiotherapy-related types of nasopharyngeal carcinoma (NPC).
Methods and materials: A total of 842 cases of NPC were randomly selected. According to 5-year follow-up results after radiotherapy, NPC was subdivided into four types: Type I (no primary and regional recurrence and no distant metastasis), Type II (primary or regional recurrence and no distant metastasis), Type III (no primary and regional recurrence, and distant metastasis), and Type IV (primary or regional recurrence, and distant metastasis). Proportion of the four types and relationship between this typing and Zhi-guang Xie typing were analyzed.
Results: Distribution of radiotherapy-related types of NPC were 50.6%, 23.2%, 20.7%, and 5.6% for Types I, II, III, and IV, respectively. For Types D and AD of Zhi-guang Xie typing system and Stage III and IV of the 1992 Fuzhou staging system, the proportion of Type III was greater than that of Type II; and for Type A and Stage I and II, there was a larger proportion of Type II than that of Type III.
Conclusion: Radiotherapy-related typing, as a new clinical subclassification, could be supplementary for previous clinical typing and staging.
Similar articles
-
[Clinical study on radiotherapy-related typing of nasopharyngeal carcinoma].Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3272-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17313809 Chinese.
-
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.Oral Oncol. 2008 Jul;44(7):703-9. doi: 10.1016/j.oraloncology.2007.09.005. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061528 Clinical Trial.
-
[Three-dimensional conformal radiotherapy for primary nasopharyngeal carcinoma and analysis of locoregional recurrence].Ai Zheng. 2006 Mar;25(3):330-4. Ai Zheng. 2006. PMID: 16536988 Chinese.
-
[Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):932-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533747 Clinical Trial. Chinese.
-
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Ear Nose Throat J. 2008. PMID: 19006065 Review.
Cited by
-
Quantitative measurement of optical attenuation coefficients of cell lines CNE1, CNE2, and NP69 using optical coherence tomography.Lasers Med Sci. 2013 Feb;28(2):621-5. doi: 10.1007/s10103-012-1124-1. Epub 2012 May 22. Lasers Med Sci. 2013. PMID: 22618158
-
RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.J Cell Mol Med. 2017 Nov;21(11):2872-2883. doi: 10.1111/jcmm.13200. Epub 2017 May 30. J Cell Mol Med. 2017. PMID: 28557284 Free PMC article.
-
CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma.Onco Targets Ther. 2016 Nov 14;9:7011-7017. doi: 10.2147/OTT.S99717. eCollection 2016. Onco Targets Ther. 2016. PMID: 27895493 Free PMC article.
-
Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study.Chin J Cancer Res. 2016 Oct;28(5):467-477. doi: 10.21147/j.issn.1000-9604.2016.05.01. Chin J Cancer Res. 2016. PMID: 27877005 Free PMC article.
-
Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.Chin J Cancer. 2016 Apr 7;35:37. doi: 10.1186/s40880-016-0098-y. Chin J Cancer. 2016. PMID: 27056488 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources